Lyka Labs has received an approval to transfer domestic marketing division of Ethical products under slump sale to Lyka Healthcare, a wholly owned subsidiary company with effect from March 01, 2014. The board of directors at its meeting held on March 28, 2014 has approved for the same.
The board also approved to invest in 35,00,000 equity shares of Rs 10 each of Lyka Exports at a premium of Rs 25 in lieu of its outstanding, subject to approval of the shareholders in the General Meeting.
Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.
